TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
PW Medtech Group Ltd. ( (HK:1358) ) has provided an update.
PW Medtech Group Ltd. announced the voluntary suspension of the review process for the subsequent listing of its subsidiary, Sichuan Ruijian Medical, on the Beijing Stock Exchange. This decision was made due to the impending expiration of the financial statement cut-off date, with the review status now adjusted to suspension. The listing process remains ongoing, subject to market conditions and regulatory approvals, and shares of Sichuan Ruijian Medical remain suspended from trading on the NEEQs.
The most recent analyst rating on (HK:1358) stock is a Buy with a HK$1.50 price target. To see the full list of analyst forecasts on PW Medtech Group Ltd. stock, see the HK:1358 Stock Forecast page.
More about PW Medtech Group Ltd.
PW Medtech Group Ltd. is a company incorporated in the Cayman Islands, operating in the medical technology industry. It focuses on providing medical products and services, with a market interest in expanding its operations and listings in various stock exchanges.
Average Trading Volume: 1,791,417
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.34B
Find detailed analytics on 1358 stock on TipRanks’ Stock Analysis page.